“…Although the origin of physiological and disease‐induced fibrinolysis in the central nervous system (CNS) remains controversial, the relationship among inflammation, coagulation, and fibrinolytic activity in CNS diseases is worth studying. CSF D‐dimer concentrations have been used to assess fibrinolytic activity in the CSF of humans with CNS infectious, neoplastic, traumatic, and vascular diseases . In addition, D‐dimers in the CSF have been proposed as markers of meningeal inflammation, and as a useful tool to differentiate between idiopathic subarachnoid hemorrhage and traumatic spinal tap .…”